ArticleJournal of laboratory and precision medicine2020

GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment.

Rami A Ballout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.